Sialic acid as a target for the development of novel antiangiogenic strategies.

Sialic acid as a target for the development of novel antiangiogenic strategies.

Future Med Chem. 2018 Dec 12;:

Authors: Chiodelli P, Urbinati C, Paiardi G, Monti E, Rusnati M

Abstract
Sialic acid is associated with glycoproteins and gangliosides of eukaryotic cells. It regulates various molecular interactions, being implicated in inflammation and cancer, where its expression is regulated by sialyltransferases and sialidases. Angiogenesis, the formation of new capillaries, takes place during inflammation and cancer, and represents the outcome of several interactions occurring at the endothelial surface among angiogenic growth factors, inhibitors, receptors, gangliosides and cell-adhesion molecules. Here, we elaborate on the evidences that many structures involved in angiogenesis are sialylated and that their interactions depend on sialic acid with implications in angiogenesis itself, inflammation and cancer. We also discuss the possibility to exploit sialic acid as a target for the development of novel antiangiogenic drugs.

PMID: 30539670 [PubMed - as supplied by publisher]

from A via a.sfakia on Inoreader https://ift.tt/2QqzS4t